Supreme Court Again Asked To Address Generic Firms' Liability For Inadequate Warning Labels
Executive Summary
Actavis is making a second appeal to the Supreme Court to consider whether a generic manufacturer can be sued for failing to add safety information to its labeling that is not in the brand's label
You may also be interested in...
McNeil Seeks Supreme Court Opinion On OTC Labeling Pre-emption
McNeil Consumer Healthcare argues in a consumer injury lawsuit that the Supreme Court's 2009 decision in Wyeth v. Levine does not apply to nonprescription pharmaceuticals because OTC and Rx drugs are covered by different regulatory labeling schemes.
McNeil Seeks Supreme Court Opinion On OTC Labeling Pre-emption
McNeil Consumer Healthcare argues in a consumer injury lawsuit that the Supreme Court's 2009 decision in Wyeth v. Levine does not apply to nonprescription pharmaceuticals because OTC and Rx drugs are covered by different regulatory labeling schemes.
Generic Manufacturers Should Be Liable For Inadequate Label Warnings, Government Says
The Solicitor General advises the Supreme Court not to take up a case involving failure-to-warn claims for the heartburn drug Reglan.